
Valo Therapeutics
An immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Enterprise value
$84—125m
Company register number
2768695-4
Recent deals
Authorizing premium user...
An immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.